Atlanta, GACIK 18820534 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
15 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Medtronic PLC | 428.8K | $41.19M | 12.9% | 0 | Held |
| 2 | Mirum Pharmaceuticals Inc | 421.2K | $33.27M | 10.4% | −114.5K | Reduced |
| 3 | Ionis Pharmaceuticals Inc | 417.8K | $33.05M | 10.4% | 0 | Held |
| 4 |
| 96.5K |
| $26.55M |
| 8.3% |
| +13.5K |
| Added |
| 5 | Biomarin Pharmaceutical Inc | 411.9K | $24.48M | 7.7% | +83.3K | Added |
| 6 | Neurocrine Biosciences Inc | 151.8K | $21.53M | 6.8% | −14.6K | Reduced |
| 7 | Unitedhealth Group Inc | 61.8K | $20.39M | 6.4% | +3.6K | Added |
| 8 | Astrazeneca PLC | 220.2K | $20.24M | 6.4% | +220.2K | New |
| 9 | Healthequity Inc | 212.9K | $19.50M | 6.1% | +212.9K | New |
| 10 | Livanova PLC | 288.9K | $17.78M | 5.6% | +121.0K | Added |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio